 But guess what happened? Now these hospitals ended up buying low and selling high. So recent studies published in German Journal of Medicine and New England Journal of Medicine found that the 340B hospitals that set a commercial price can be as high as three to eight times of the least price of the drugs. And their markups are higher than the markups of non-340B hospitals and the physician practices.